Press release
SmartWork Media Acquires ST Media Group Intl.
Sign of The Times, BXP, Screen Printing, Big Picture, VMSD, IRDC and BXP Live will build out SmartWork Media?s B2B portfolio.
“SmartWork Media has a stable of powerful award-winning B2B titles and is eager to build on this success. ST Media Group’s B2B titles are a seamless fit into SWM’s operations,” says Matthijs Braakman, CEO of SmartWork Media. “For more than 100 years, ST Media Group has positioned its B2B magazines, events and digital platforms as market leading products. SWM is proud to take ownership and build on the solid foundation of each brand. Our combined expertise will accelerate the transformation of all ST Media’s titles to leading-edge, dynamic and responsive multimedia content platforms to better serve the professional marketers in each unique industry.”
SmartWork Media’s portfolio of brands will expand from INSTORE, INVISION and PETS+ to include Signs of The Times, VMSD, Big Picture, BXP and Screen Printing. Each brand is supported by multimedia platforms including print magazines, websites, newsletters, content marketing services, live and virtual events (EyeInnovate, Pets+ Summit, IRDC, BXP Live), and other professional marketing solutions.
28 Valley Road, Suite 1, Montclair, NJ 07042
Press Contact:
Matthijs Braakman, CEO
matthijs@smartworkmedia.com
P: 212-981-9625
ABOUT SMARTWORK MEDIA: SmartWork Media is dedicated to the idea that business media should strive to inform, excite and inspire business readers, and that a good business magazine can (and should) have the energy and compulsive readability of a top consumer publication. The company publishes INSTORE, INVISION and PETS+ magazines as well as websites, events and media services for each industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SmartWork Media Acquires ST Media Group Intl. here
News-ID: 2134754 • Views: …
More Releases for BXP
IO-Link Market Size Analysis, Strategic Assessment, Market Growth and Forecasts …
The IO-Link Market is Valued USD 8.763 billion in 2024 and projected to reach USD 75.3 billion by 2032, growing at a CAGR of 27.0% During the Forecast period of 2024-2032. IO-link is an open standard serial communication protocol that allows for the bidirectional exchange of data from sensors and devices that support IO-link and are connected to a master. The master works as a gateway for the connection of…
Lithium Tert-Butoxide Market Size, Share and Forecast By Key Players-American El …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Lithium Tert-Butoxide market is anticipated to grow at a compound annual growth rate (CAGR) of 7.1% between 2024 and 2031. The market is expected to grow to USD 5.68 Billion by 2024. The valuation is expected to reach USD 9.19 Billion by 2031.
Due to its increased application as a catalyst and reagent in a variety of chemical reactions, particularly in the…
Fab Foundation to Establish Global Headquarters in Kendall Square, Cambridge
The Fab Foundation proudly announces the establishment of its global headquarters and flagship Fab Lab in the heart of Kendall Square in Cambridge, MA. A pioneering partnership with BXP, the development of this new community resource marks a historic milestone for Cambridge, the Greater Boston area, and the Fab Lab Network.
Located at 325 Main Street in Kendall Square, the new headquarters will be a living laboratory, providing access to…
Favipiravir Market Provides in-depth analysis of the Industry, with Current Tren …
Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Favipiravir was discovered through screening chemical library for anti-viral activity against the influenza virus by Toyama Chemical Co., Ltd. Favipiravir undergoes an intracellular phosphoribosylation to be an active form, favipiravir-RTP (favipiravir ribofuranosyl-5'-triphosphate), which is recognized as a substrate by RdRp, and inhibits the RNA polymerase activity.
Since the catalytic domain of…
